Clinical Trial Update: The Effect of Intranasal Insulin on Motor and Non-motor Symptoms in Parkinson's Disease Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intranasal insulin for motor and non-motor symptoms in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Intranasal insulin (insulin)

Snippet

Sponsor: dr.dargahi | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED